4
Changes in Ownership
Vericel Corp Filed Acc 0001140361-24-046456
Director sold 5,000 shares at an average $56.25 ($281,250)
- Director acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ZERBE ROBERT L MD Director | 2024-11-11 | Option exercise 10b5-1 | +2,500 | $13.05 | $32,625 | 29,095 | D |
| ZERBE ROBERT L MD Director | 2024-11-11 | Sale 10b5-1 | −2,500 | $55.00 | $137,500 | 26,595 | D |
| ZERBE ROBERT L MD Director | 2024-11-12 | Option exercise 10b5-1 | +2,500 | $13.05 | $32,625 | 29,095 | D |
| ZERBE ROBERT L MD Director | 2024-11-12 | Sale 10b5-1 | −2,500 | $57.50 | $143,750 | 26,595 | D |
| Derivatives | |||||||
| ZERBE ROBERT L MD Director | 2024-11-11 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 15,000 | D | ||
| ZERBE ROBERT L MD Director | 2024-11-12 | Option exercise · Stock Option (Right to Buy) 10b5-1 | +2,500 | 12,500 | D | ||
| Open-market sales · 5,000 sh · avg $56.25 · $281,250 | |||||||
Loading xslF345X05/form4.xml…